# Filing Detail

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-25-029464
Filing Date
2025-04-07
Accepted
2025-04-07 16:58:10
Documents
98
Period of Report
2024-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ANNUAL REPORT | ea0237295-20f_neuro.htm iXBRL | 20-F | 2006988
2 | AMENDED AND RESTATED ARTICLES OF ASSOCIATION | ea023729501ex1-1_neuro.htm | EX-1.1 | 285033
3 | DESCRIPTION OF THE REGISTRANT'S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF | ea023729501ex2-1_neuro.htm | EX-2.1 | 55440
4 | 2018 SHARE INCENTIVE PLAN | ea023729501ex4-2_neuro.htm | EX-4.2 | 147637
5 | INSIDER TRADING POLICY | ea023729501ex11-1_neuro.htm | EX-11.1 | 82866
6 | CERTIFICATION | ea023729501ex12-1_neuro.htm | EX-12.1 | 9989
7 | CERTIFICATION | ea023729501ex12-2_neuro.htm | EX-12.2 | 10146
8 | CERTIFICATION | ea023729501ex13-1_neuro.htm | EX-13.1 | 3429
9 | CERTIFICATION | ea023729501ex13-2_neuro.htm | EX-13.2 | 3529
10 | CONSENT OF SOMEKH CHAIKIN (MEMBER FIRM OF KPMG INTERNATIONAL), INDEPENDENT REGIS | ea023729501ex15-1_neuro.htm | EX-15.1 | 2137
11 | GRAPHIC | image_001.jpg | GRAPHIC | 13938
| Complete submission text file | 0001213900-25-029464.txt |  | 8314667

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
12 | XBRL SCHEMA FILE | nrsn-20241231.xsd | EX-101.SCH | 60639
13 | XBRL CALCULATION FILE | nrsn-20241231_cal.xml | EX-101.CAL | 40413
14 | XBRL DEFINITION FILE | nrsn-20241231_def.xml | EX-101.DEF | 309437
15 | XBRL LABEL FILE | nrsn-20241231_lab.xml | EX-101.LAB | 539980
16 | XBRL PRESENTATION FILE | nrsn-20241231_pre.xml | EX-101.PRE | 320441
101 | EXTRACTED XBRL INSTANCE DOCUMENT | ea0237295-20f_neuro_htm.xml | XML | 755009

Mailing Address 11 HAMENOFIM ST. BUILDING B HERZLIYA L3 4672562
Business Address 11 HAMENOFIM ST. BUILDING B HERZLIYA L3 4672562 972-9-9531142
NeuroSense Therapeutics Ltd. (Filer) CIK: 0001875091 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-41084 | Film No.: 25818843
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)